---
layout: theophylline_style
title:  "Factor Xa aptamer"
date:   2024-04-16 00:00:00
author: Bichun Wu, Zhaoji Qiu
categories: Aptamer
---

<div class="content-section">

<div class="content-section">

<div class="content-section">

<div class="content-section">

<div class="content-section">

<br>
<br>

</div>

<div class="content-section">
<h2 class="section-title" id="timeline">Timeline</h2>
<div class="timeline">
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/20022942/" target="_blank" style="color:#520049">2009</a></h3>
    </div>
    <div class="body">
      <p>An RNA aptamer (RNA11F7t), which was selected from a combinatorial library for its ability to bind factor Xa<sup>[<a href="#ref1" style="color:#520049">1</a>]</sup></p>
    </div>
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/29863725/" target="_blank" style="color:#520049">2018</a></h3>
    </div>
    <div class="body">
      <p>They solved X-ray crystal structures of the aptamer bound to factor Xa (FXa)<sup>[<a href="#ref3" style="color:#520049">3</a>]</sup></p>
    </div>
    <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/35021888/" target="_blank" style="color:#520049">2022</a></h3>
    </div>
    <div class="body">
      <p>The combination of factor X/Xa aptamer and UFH has significantly improved anticoagulant properties compared to UFH alone<sup>[<a href="#ref4" style="color:#520049">4</a>]</sup></p>
    </div>

<div class="content-section">
<h2 class="section-title" id="description">Description</h2>
<p>In 2009, Krishnaswamy, S. et al. presented the characterization of an RNA aptamer (RNA11f7t) that was developed by cyclical screening of a combinatorial library against factor Xa. They showed that the potent inhibition of thrombin formation catalyzed by prothrombinase unexpectedly resulted from the ability of RNA11f7t to bind factor Xa with high affinity and inhibit its interaction with factor Va on the membrane surface. In 2018, Sullenger, B. A. et al. determined the X-ray crystal structures of the aptamer bound to factor Xa (FXa). They demonstrated that combinations of 11F7t and catalytic-site FXa inhibitors enhance anticoagulation in purified reaction mixtures and plasma<sup>[<a href="#ref1" style="color:#520049">1</a></sup><sup>,<a href="#ref3" style="color:#520049">3</a></sup><sup>]</sup>.<br></p>
<br>
<br>

</div>

<div class="content-section">
<h2 class="section-title" id="SELEX">SELEX</h2>
<p>Krishnaswamy, S. et al. presented the characterization of an RNA aptamer (RNA11f7t) which had been developed by cyclical screening of a combinatorial library against factor Xa. They showed that the potent inhibition of thrombin formation, catalyzed by prothrombinase, unexpectedly resulted from the ability of RNA11f7t to bind factor Xa with high affinity and inhibit its interaction with factor Va on the membrane surface. After 11 rounds of selection, the products were digested with EcoR1 and BamH1 (New England Biolabs) and directionally cloned into pUC19 that had been linearized with the same enzymes. Individual clones were sequenced, and clonal RNA transcripts were analyzed in filter-binding assays. The lead molecule was systematically shortened to obtain a truncated version (RNA11F7t) that retained binding activity<sup>[<a href="#ref1" style="color:#520049">1</a>]</sup>.</p>
<p>Detailed information are accessible on <a href="{{ site.url }}{{ site.baseurl }}/SELEX" target="_blank" style="color:#520049"><b><i>SELEX</i></b></a> page.</p>
<br>
<br>  

</div>

<div class="content-section">
<h2 class="section-title" id="Structure">Structure</h2>
<div class="blowheader_box">2D representation</div>
<p>FXa aptamer—11F7t, mFold predicted structure, 36 nts in length. Here we used ribodraw to complete the figure, through the 3D structure information. 11F7t was named by Krishnaswamy, S in the article<sup>[<a href="#ref2" style="color:#520049">2</a></sup><sup>,<a href="#ref4" style="color:#520049">4</a></sup><sup>]</sup>.</p>
<p>5'-GAGAGCCCCAGCGAGAUAAUACUUGGCCCCGCUCUU-3'</p>
<img src="/images/2D/FXa_aptamer_2D.svg" alt="drawing" style="width:800px;height:350px;display:block;margin:0 auto;border-radius:0;" class="img-responsive">
<div style="display: flex; justify-content: center;"></div>

<div class="blowheader_box">3D visualisation</div>             
<p>Sullenger, B. A. et al. able to crystallize and determine the structure of a ternary complex between GD-FXa_S195A, 11F7t, and rivaroxaban bound to the active site of the proteinase at 2.25 Å resolution. The PDB ID of this structure is 5VOF<sup>[<a href="#ref3" style="color:#520049">3</a></sup><sup>]</sup>.</p>
<p>Additional available structures that have been solved and detailed information are accessible on <a href="{{ site.url }}{{ site.baseurl }}/structures" target="_blank" style="color:#520049"><b><i>Structures</i></b></a> page.</p>
<div><p style="text-align:right;margin-bottom: 0px;">(Clicking the "Settings/Controls info" to turn Spin off)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
  <table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;"><tr>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/3D/FXa_aptamer_3D1.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
      <meta charset="utf-8" />
      <meta name="viewport" content="width=device-width, user-scalable=no, minimum-scale=1.0, maximum-scale=1.0">
      <meta http-equiv="X-UA-Compatible" content="IE=edge">
      <title>PDBe Molstar</title>
      <!-- Molstar CSS & JS -->
      <link rel="stylesheet" type="text/css" href="https://www.ebi.ac.uk/pdbe/pdb-component-library/css/pdbe-molstar-1.2.1.css">
      <script src="/js/mol/pdbe-molstar-plugin.js"></script>
    <body onload="customize()">
        <div class="controlsSection1">
            <button onclick="
              var selectSections1 = [
                {
  struct_asym_id: 'A',    
  start_residue_number:1, 
  end_residue_number:6, 
  color:{r:184,g:51,b:50}
},
{
  struct_asym_id: 'A', 
  start_residue_number:7, 
  end_residue_number:7, 
  color:{r:46,g:161,b:3}
},
{
  struct_asym_id: 'A', 
  start_residue_number:8, 
  end_residue_number:8, 
  color:{r:241,g:125,b:7}
},
{
  struct_asym_id: 'A', 
  start_residue_number:9, 
  end_residue_number:9, 
  color:{r:46,g:161,b:3}
},
{
  struct_asym_id: 'A', 
  start_residue_number:10, 
  end_residue_number:10, 
  color:{rr:241,g:125,b:7}
},
{
  struct_asym_id: 'A', 
  start_residue_number:11, 
  end_residue_number:12, 
  color:{r:46,g:161,b:3}
},
{
  struct_asym_id: 'A', 
  start_residue_number:13, 
  end_residue_number:24,
  color:{r:8,g:69,b:149}
},
{
  struct_asym_id: 'A', 
  start_residue_number:25, 
  end_residue_number:27,
  color:{r:46,g:161,b:3}
},
{
  struct_asym_id: 'A', 
  start_residue_number:28, 
  end_residue_number:28,
  color:{r:241,g:125,b:7}
},
{
  struct_asym_id: 'A', 
  start_residue_number:29, 
  end_residue_number:29,
  color:{r:46, g:161,b:3}
},
{
  struct_asym_id: 'A', 
  start_residue_number:30, 
  end_residue_number:30,
  color:{r:241, g:125,b:7}
},
{
  struct_asym_id: 'A', 
  start_residue_number:31, 
  end_residue_number:36, 
  color:{r:184,g:51,b:50}
},
{
  struct_asym_id: 'H', 
  start_residue_number:16, 
  end_residue_number:301, 
  color:{r:207,g:62,b:125}
},
{
  struct_asym_id: 'L', 
  start_residue_number:88, 
  end_residue_number:138, 
  color:{r:207,g:62,b:125}
}
              ]
            viewerInstance1.visual.select({ data: selectSections1, nonSelectedColor: {r:255,g:255,b:255}})" style="float:right;height:25px;width: 120px;">Color Selection</button><br><br>
          <button button style="float: left;height:25px;width: 120px;" onclick="viewerInstance1.visual.clearSelection()">Clear Selection</button><br><br>
      </div>
    <div class="viewerSection1">
    <!-- Molstar container -->
      <div id="myViewer1"></div>
    
</body>
</td>
</tr>
</table>
</div>

<div class="blowheader_box">Binding pocket</div>             
<p>Left: Surface representation of the binding pocket of the aptamer generated from PDB ID: 5VOF by X-ray crystallography. GD-FXa<sup>S195A</sup> (shown in vacuumm electrostatics), blue is positive charge, red is negative charge. Right: The hydrogen bonds of binding sites of the aptamer bound with GD-FXa<sup>S195A</sup>.</p>
  <table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;"><tr>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/Binding_pocket/FXa_aptamer_binding_pocket1.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  <td style="text-align:center;padding-bottom: 0px;padding-right: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/Binding_pocket/FXa_aptamer_binding_pocket2.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  </tr>
  </table>
  <br>
  <br>

</div>

<div class="content-section">
<h2 class="section-title" id="ligand-recognition">Ligand information</h2> 
<div class="blowheader_box">SELEX ligand</div>
<p>The dependence of the initial rate of thrombin formation on increasing concentrations of factor Va at different fixed concentrations of aptamer was analyzed by assuming mutually exclusive binding interactions in rapid equilibrium between factor Va versus Xa and aptamer. Analysis according to the cubic equation of the reference yielded fitted values for Kd for the membrane-dependent interaction between Xa and Va (Kd Xa, Va), the number of moles of Va bound per mole of Xa at saturation, Kd for aptamer binding to Xa (Kd RNA, Xa), the number of moles of aptamer bound per mole of Xa at saturation, the rate at zero Va, and the rate at infinite Va<sup>[<a href="#ref1" style="color:#520049">1</a>]</sup>.</p>
<div style="display: flex; justify-content: center;">
<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(0)">Name</th>
        <!--th onclick="sortTable(0)">Sequence</th-->
        <th onclick="sortTable(0)">Ligand</th>
        <th onclick="sortTable(0)">Affinity</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td0">Factor Xa aptamer</td>
        <!--td name="td1">UGGGGUAUCGCCAAGCGGUAAGGCACCGGAUUCUGAUUCCGGCAUUCCGAGGUUCGAAUCCUCGUACCCCAGCCA</td-->
        <td name="td3">Factor Xa</td>
        <td name="td4">1.1 ± 0.2 nM</td>
      </tr>
	  </tbody>
  </table>
  </div>

<div class="blowheader_box">Structure ligand</div>
<p>Rivaroxaban is a factor Xa inhibitor used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). May also be used as thrombosis prophylaxis in specific situations.-----From <a href="https://go.drugbank.com/drugs/DB06228" target="_blank" style="color:#520049; text-decoration: underline;"><b>Drugbank</b></a></p>

<p class="dot-paragraph"><b>PubChem CID:</b> a unique identifier for substances in the <a href="https://pubchem.ncbi.nlm.nih.gov/" target="_blank" style="color:#520049; text-decoration: underline;"><b>PubChem database</b></a>.</p>
<p class="dot-paragraph"><b><a href="https://commonchemistry.cas.org/" target="_blank" style="color:#520049; text-decoration: underline;"><b>CAS</b></a> number:</b> a global registry number for chemical substances.</p>
<p class="dot-paragraph"><b><a href="https://go.drugbank.com/" target="_blank" style="color:#520049; text-decoration: underline;"><b>Drugbank</b></a>:</b> a comprehensive database with detailed information on drugs and drug targets.</p>

<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(6)">Name</th>
        <th onclick="sortTable(0)">PubChem CID</th>
        <th onclick="sortTable(1)">Molecular Formula</th>
        <th onclick="sortTable(2)">Molecular Weight</th>
        <th onclick="sortTable(3)">CAS</th>
        <th onclick="sortTable(4)">Solubility</th>
        <th onclick="sortTable(5)">Drugbank ID</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td6">Rivaroxaban</td>
        <td name="td0"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/9875401" target="_blank" style="color:#520049"><b>9875401</b> </a></td>
        <td name="td1">C<sub>19</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>5</sub>S</td>
        <td name="td2">435.9 g/mol</td>
        <td name="td3"><a href="https://commonchemistry.cas.org/detail?cas_rn=366789-02-8" target="_blank" style="color:#520049"><b>366789-02-8</b></a></td>
        <td name="td4">50 mg/ml (in DMSO)</td>
        <td name="td5"><a href="https://go.drugbank.com/drugs/DB06228" target="_blank" style="color:#520049"><b>DB06228</b> </a></td>
      </tr>
	  </tbody>
  </table>
<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;"><tr>
<td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px"><img src="/images/Structure_ligand/FXa_aptamer_stru_ligand1.svg" alt="drawing" style="width:400px"  px="" /></td>
<td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px"><img src="/images/Structure_ligand/FXa_aptamer_stru_ligand2.svg" alt="drawing" style="width:400px"  px="" /></td>
</tr>
</table>
<div style="display: flex; justify-content: center;"></div>
<br>

<p>Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting.-----From <a href="https://www.uniprot.org/uniprotkb/P00742/entry" target="_blank" style="color:#520049; text-decoration: underline;"><b>Uniprot</b></a></p>

<p class="dot-paragraph"><b>UniProt ID:</b> uniquely identifies protein sequences in the <a href="https://www.uniprot.org/" target="_blank" style="color:#520049; text-decoration: underline;"><b>UniProt database</b></a>, a resource for protein information.</p>
<p class="dot-paragraph"><b><a href="https://www.ebi.ac.uk/interpro/" target="_blank" style="color:#520049; text-decoration: underline;"><b>Pfam</b></a>:</b> a widely recognised database of protein families and domains.</p>
<p class="dot-paragraph"><b><a href="https://www.ncbi.nlm.nih.gov/genbank/" target="_blank" style="color:#520049; text-decoration: underline;"><b>GenBank</b></a>:</b> maintained by <a href="https://www.ncbi.nlm.nih.gov/" target="_blank" style="color:#520049; text-decoration: underline;"><b>NCBI</b></a>(National Center for Biotechnology Information), is a database of nucleotide sequences from various organisms, vital for genetic and molecular biology research.</p>
<p class="dot-paragraph"><b><a href="https://en.wikipedia.org/wiki/Mass" target="_blank" style="color:#520049; text-decoration: underline;"><b>Mass</b></a>:</b> an intrinsic property of a body.</p>

<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(0)">Uniprot ID</th>
        <th onclick="sortTable(1)">Pfam</th>
        <th onclick="sortTable(2)">Mass</th>
        <th onclick="sortTable(3)">Protein sequence</th>
        <th onclick="sortTable(4)">PDB ID</th>
        <th onclick="sortTable(5)">GenBank</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td0"><a href="https://www.uniprot.org/uniprotkb/P00742/entry" target="_blank" style="color:#520049"><b>P00742</b></a></td>
        <td name="td1"><a href="https://www.ebi.ac.uk/interpro/entry/pirsf/PIRSF001143/" target="_blank" style="color:#520049"><b>PIRSF001143</b></a></td>
        <td name="td2">28.51 kDa</td>
        <td name="td3">
        <div class="sequence-container">
          <span class="sequence-text">GGPYLQ</span>
          <span class="show-more" onclick="toggleSequence(event)">......</span>
          <span class="full-sequence">IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK</span>
        </div>
      </td>
        <td name="td4"><a href="https://www.rcsb.org/structure/1FAX" target="_blank" style="color:#520049"><b>1FAX</b></a></td>
        <td name="td5"><a href="https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?lvl=0&id=9606" target="_blank" style="color:#520049"><b>9606</b> </a></td>
      </tr>
	  </tbody>
  </table>
 <table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;"><tr>
<td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px"><img src="/images/Structure_ligand/FXa_aptamer_stru_ligand3.svg" alt="drawing" style="width:800px"  px="" /></td>
</tr>
</table>
<div style="display: flex; justify-content: center;"></div>

<div class="blowheader_box">Similar compound</div>
<p>We used the <a href="http://ekhidna2.biocenter.helsinki.fi/dali/#:~:text=The%20Dali%20server%20is%20a%20network%20service%20for%20comparing%20protein" target="_blank" style="color:#520049; text-decoration: underline;"><b>Dail server website</b></a> to compare the structural similarities of ligand proteins, and selected the previous information with high similarity for presentation.</p>

<p class="dot-paragraph"><a href="http://ekhidna2.biocenter.helsinki.fi/dali/#:~:text=The%20Dali%20server%20is%20a%20network%20service%20for%20comparing%20protein" target="_blank" style="color:#520049; text-decoration: underline;"><b>Dail server website</b></a>: a network service for comparing protein structures in 3D. Dali compares them against those in the <a href="https://www.rcsb.org/" target="_blank" style="color:#520049; text-decoration: underline;"><b>Protein Data Bank</b></a> (PDB).</p>
<p class="dot-paragraph"><b><a href="https://en.wikipedia.org/wiki/Standard_score" target="_blank" style="color:#520049; text-decoration: underline;"><b>Z-score</b></a>:</b> a standard score that is converted from an original score. The list of neighbours is sorted by Z-score. Similarities with a Z-score lower than 2 are spurious.</p>
<p class="dot-paragraph"><b><a href="https://en.wikipedia.org/wiki/Root_mean_square_deviation" target="_blank" style="color:#520049; text-decoration: underline;"><b>RMSD</b></a>:</b> (Root Mean Square Deviation) is used to measure the degree to which atoms deviate from the alignment position.</p>
<p class="dot-paragraph"><b>PDB:</b> PDB ID+ chain name.</p>

<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(1)">PDB</th>
        <th onclick="sortTable(2)">Z-score</th>
        <th onclick="sortTable(3)">RMSD</th>
        <th onclick="sortTable(4)">Description</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td1">5VOF-H</td>
        <td name="td2">48.5</td>
        <td name="td3">0</td>
        <td name="td4">Coagulation factor x</td>
      </tr>
      <tr>
        <td name="td1">5VOE-H</td>
        <td name="td2">46.4</td>
        <td name="td3">0.3</td>
        <td name="td4">Coagulation factor x</td>
      </tr>
      <tr>
        <td name="td1">2Y5G-A</td>
        <td name="td2">45.8</td>
        <td name="td3">0.4</td>
        <td name="td4">Activated factor xa heavy</td>
      </tr>
      <tr>
        <td name="td1">2JKH-A</td>
        <td name="td2">45.8</td>
        <td name="td3">0.4</td>
        <td name="td4">Activated factor xa heavy</td>
      </tr>
      <tr>
        <td name="td1">2XC4-A</td>
        <td name="td2">45.8</td>
        <td name="td3">0.4</td>
        <td name="td4">Activated factor xa heavy</td>
      </tr>
      <tr>
        <td name="td1">3IIT-A</td>
        <td name="td2">45.8</td>
        <td name="td3">0.4</td>
        <td name="td4">Activated factor xa heavy</td>
      </tr>
      <tr>
        <td name="td1">2Y5F-A</td>
        <td name="td2">45.8</td>
        <td name="td3">0.4</td>
        <td name="td4">Activated factor xa heavy</td>
      </tr>
      <tr>
        <td name="td1">2Y5H-A</td>
        <td name="td2">45.7</td>
        <td name="td3">0.4</td>
        <td name="td4">Activated factor xa heavy</td>
      </tr>
      <tr>
        <td name="td1">2EI8-A</td>
        <td name="td2">45.7</td>
        <td name="td3">0.4</td>
        <td name="td4">Coagulation factor x, heavy</td>
      </tr>
      <tr>
        <td name="td1">3TK5-A</td>
        <td name="td2">45.6</td>
        <td name="td3">0.4</td>
        <td name="td4">Factor x heavy chain</td>
      </tr>
	  </tbody>
  </table>
<br>
<br>

                 

</div>

<div class="content-section">
<h2 class="section-title" id="references">References</h2>
                
<a id="ref1"></a><font><strong>[1] An Anticoagulant RNA Aptamer That Inhibits Proteinase-Cofactor Interactions within Prothrombinase.</strong></font><br />
Buddai, S. K., Layzer, J. M., Lu, G., Rusconi, C. P., Sullenger, B. A., Monroe, D. M., & Krishnaswamy, S.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/20022942/" target="_blank" style="color:#520049" >The Journal of biological chemistry, 285(8), 5212–5223. (2009)</a>
<br />
                
<a id="ref2"></a><font><strong>[2] Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant.</strong></font><br />
Soule, E. E., Bompiani, K. M., Woodruff, R. S., & Sullenger, B. A.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/26584417/" target="_blank" style="color:#520049">Nucleic acid therapeutics, 26(1), 1–9. (2016)</a>
<br />
                
<a id="ref3"></a><font><strong>[3] Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass.</strong></font><br />
Gunaratne, R., Kumar, S., Frederiksen, J. W., Stayrook, S., Lohrmann, J. L., Perry, K., Bompiani, K. M., Chabata, C. V., Thalji, N. K., Ho, M. D., Arepally, G., Camire, R. M., Krishnaswamy, S., & Sullenger, B. A.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/29863725/" target="_blank" style="color:#520049">Nature biotechnology, 36(7), 606–613. (2018)</a>
<br />
                
<a id="ref4"></a><font><strong>[4] Combining Heparin and a FX/Xa Aptamer to Reduce Thrombin Generation in Cardiopulmonary Bypass and COVID-19.</strong></font><br />
Chabata, C. V., Frederiksen, J. W., Olson, L. B., Naqvi, I. A., Hall, S. E., Gunaratne, R., Kraft, B. D., Que, L. G., Chen, L., & Sullenger, B. A.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/35021888/" target="_blank" style="color:#520049">Nucleic acid therapeutics, 32(3), 139–150. (2022)</a>
<br />

</div>

